دسترسی عمومی

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination‏

N Pardi, MJ Hogan, RS Pelc, H Muramatsu, H Andersen, CR DeMaso, ...‏

Nature 543 (7644), 248-251, 2017‏

تعهدات: US National Institutes of Health‏

[HTML] nature.com

Mosaic vaccines elicit CD8⁺ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys‏

S Santra, HX Liao, R Zhang, M Muldoon, S Watson, W Fischer, J Theiler, ...‏

Nature medicine 16 (3), 324-328, 2010‏

تعهدات: US National Institutes of Health‏

Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys‏

NL Letvin, SS Rao, DC Montefiori, MS Seaman, Y Sun, SY Lim, WW Yeh, ...‏

Science translational medicine 3 (81), 81ra36-81ra36, 2011‏

تعهدات: US National Institutes of Health‏

[HTML] nature.com

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge‏

T Bradley, J Pollara, S Santra, N Vandergrift, S Pittala, C Bailey-Kellogg, ...‏

Nature communications 8 (1), 15711, 2017‏

تعهدات: Bill & Melinda Gates Foundation, US Department of Defense, US National …‏

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection‏

A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ...‏

Cell reports Medicine 2 (4), 2021‏

تعهدات: National Health and Medical Research Council, Australia‏

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability‏

DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ...‏

Immunity 54 (12), 2908-2921. e6, 2021‏

تعهدات: Australian Research Council, National Health and Medical Research Council …‏

Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib‏

D Dumka, P Puri, N Carayol, C Lumby, H Balachandran, K Schuster, ...‏

Leukemia & lymphoma 50 (12), 2017-2029, 2009‏

تعهدات: US National Institutes of Health‏

[HTML] sciencedirect.com

Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens‏

S Santra, M Muldoon, S Watson, A Buzby, H Balachandran, KR Carlson, ...‏

Virology 428 (2), 121-127, 2012‏

تعهدات: US National Institutes of Health‏

[PDF] cell.com

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses‏

H Balachandran, C Phetsouphanh, D Agapiou, A Adhikari, C Rodrigo, ...‏

Cell reports 38 (6), 2022‏

تعهدات: National Health and Medical Research Council, Australia‏

[PDF] asm.org

Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus, and trivalent mosaic envelope vaccines formulated as a DNA prime, NYVAC, and …‏

SL Hulot, B Korber, EE Giorgi, N Vandergrift, KO Saunders, ...‏

Journal of virology 89 (12), 6462-6480, 2015‏

تعهدات: US National Institutes of Health‏

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents‏

P Garcia-Valtanen, CM Hope, MG Masavuli, AEL Yeow, H Balachandran, ...‏

Cell Reports Medicine 3 (6), 2022‏

تعهدات: US National Institutes of Health‏

[HTML] sciencedirect.com

Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease‏

RC Zahn, MD Rett, M Li, H Tang, B Korioth-Schmitz, H Balachandran, ...‏

Blood, The Journal of the American Society of Hematology 115 (15), 3070-3078, 2010‏

تعهدات: US National Institutes of Health‏

Immunization with an SIV-based IDLV expressing HIV-1 Env 1086 clade C elicits durable humoral and cellular responses in rhesus macaques‏

D Negri, M Blasi, C LaBranche, R Parks, H Balachandran, M Lifton, ...‏

Molecular Therapy 24 (11), 2021-2032, 2016‏

تعهدات: US National Institutes of Health, Government of Italy‏

[HTML] nature.com

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients‏

R Rouet, JY Henry, MD Johansen, M Sobti, H Balachandran, DB Langley, ...‏

Nature communications 14 (1), 687, 2023‏

تعهدات: Australian Research Council, National Health and Medical Research Council …‏

[HTML] sciencedirect.com

Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes‏

M Asmal, C Luedemann, CL Lavine, LV Mach, H Balachandran, ...‏

Virology 475, 37-45, 2015‏

تعهدات: Bill & Melinda Gates Foundation, US National Institutes of Health‏

[HTML] oup.com

Strong, but age-dependent, protection elicited by a deoxyribonucleic acid/modified vaccinia Ankara simian immunodeficiency virus vaccine‏

V Chamcha, S Kannanganat, S Gangadhara, R Nabi, PA Kozlowski, ...‏

Open forum infectious diseases 3 (1), ofw034, 2016‏

تعهدات: US National Institutes of Health‏

[PDF] asm.org

Recombinant Mycobacterium bovis bacillus Calmette-Guerin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques‏

JD Sixsmith, MW Panas, S Lee, GO Gillard, KA White, MA Lifton, ...‏

Clinical and Vaccine Immunology 21 (10), 1385-1395, 2014‏

تعهدات: US National Institutes of Health‏

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates‏

DL Bolton, S Santra, C Swett-Tapia, J Custers, K Song, H Balachandran, ...‏

Vaccine 30 (41), 5991-5998, 2012‏

تعهدات: US National Institutes of Health‏

[PDF] asm.org

Immunogenicity of NYVAC prime-protein boost human immunodeficiency virus type 1 envelope vaccination and simian-human immunodeficiency virus challenge of nonhuman primates‏

KO Saunders, S Santra, R Parks, NL Yates, LL Sutherland, RM Scearce, ...‏

Journal of virology 92 (8), 10.1128/jvi. 02035-17, 2018‏

تعهدات: US National Institutes of Health‏

[HTML] wiley.com